SEC Filings | Clearside Biomedical, Inc.- IR Site

Filing date	Form	Description	View
Jun 03, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-20-034062.pdf 0001209191-20-034062.rtf 0001209191-20-034062.xls
May 22, 2020	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001193125-20-150268.pdf 0001193125-20-150268.rtf
May 22, 2020	EFFECT	EFFECT	View HTML 9999999995-20-001244.xls
May 21, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-20-031325.pdf 0001209191-20-031325.rtf 0001209191-20-031325.xls
May 20, 2020	CORRESP	CORRESP	View HTML 0001193125-20-147430.xls
May 19, 2020	S-3/A	Pre-effective amendment to an S-3 filing	View HTML 0001193125-20-145277.pdf 0001193125-20-145277.rtf 0001193125-20-145277.xls
May 18, 2020	CORRESP	CORRESP	View HTML 0001193125-20-145280.xls
May 14, 2020	UPLOAD	UPLOAD	View HTML
May 13, 2020	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-20-028794.pdf 0001209191-20-028794.rtf 0001209191-20-028794.xls
May 08, 2020	8-K	Report of unscheduled material events or corporate event	View HTML 0001564590-20-023233.pdf 0001564590-20-023233.rtf 0001564590-20-023233.xls

Data provided by Kaleidoscope.